PET/MRI scan for primary sclerosing cholangitis
Treatments studied
Part of Digestive system clinical trials.
This study uses a special PET/MRI scanner to take detailed pictures of your liver and bile ducts. It may help doctors better understand and manage PSC without any treatment or medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with large duct primary sclerosing cholangitis (PSC), a liver condition that affects the bile ducts.
- You are 18 to 85 years old.
- You have no other cause of liver disease, like viral hepatitis or alcohol-related liver disease.
- You do not have any metal implants or devices (like a pacemaker) that are unsafe for MRI.
- You do not have severe kidney problems, bleeding disorders, or a history of major head trauma.
- You are not pregnant or breastfeeding, and you can lie still inside the scanner for the imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with primary sclerosing cholangitis (PSC) over time to learn more about the condition. It is observational, meaning no new treatments are tested—just regular checkups and data collection to better understand PSC.
This study collects bile and uses it to grow small lab models (organoids) from people with primary sclerosing cholangitis (PSC) and from people without PSC. Researchers want to better understand how PSC changes bile cells, which could improve future diagnosis or treatments.
This trial tests whether fenofibrate can prevent primary sclerosing cholangitis (PSC) from coming back after a liver transplant. It is for adults who had a liver transplant for PSC between 1 and 7 years ago and have certain risk factors.
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
This Phase 2 trial studies a “detoxification” approach to improve liver and bile-duct function in people with primary sclerosing cholangitis (PSC). It may help lower abnormal bile flow markers and see whether the treatment is safe for your liver.
Hear when a new PSC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.